Characterisation of the First Complete Dengue Genome in Sierra Leone.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Campbell Allan K O, Omah Ifeanyi, Diouf Andy M, Ndiaye Mignane, Campbell Julian S O, Parker Edyth, Folorunso Vidalyn, Williams Anu J, Kroma Mattu T, Mani Sia Y, Daniel-Sesay Naomi, Souma Zein, Miller Choe, Lansana Roberta, Kargbo Amanda M, Chalobah Fay, Cisse Mamadou, Jallow Mamadou Malado, Charles Joseph, Koroma Aminata T, Kanu Joseph Sam, Kebede Abebaw, Tanui Collins, Tessema Sofonias, Faye Oumar, Fall Gamou, Dia Ndongo, Squire James S, Jalloh Mohamed Boie, Vandi Mohamed Alex, Koroma Zikan, Sow Abdourahmane, Sahr Foday, Sow Bocar, Harding Doris, Diallo Boubacar
Аннотация
Dengue is the leading mosquito-borne viral cause of human illness and death. More than four billion people globally are at risk of dengue virus (DENV) infection, and most infections are asymptomatic or present with a non-specific febrile illness. We characterise the first complete DENV-2 genome from Sierra Leone, recovered from a febrile adult who tested RT-PCR-positive. The sequence was identified as DENV-2 genotype II, lineage F.1.1. Phylogenetically, the Sierra Leone genome formed a well-supported sister lineage with a 2024 USA DENV-2 genome; both were nested within but clearly diverged from Indian DENV-2 sequences (2021-2022) and were distinct from the Réunion DENV-2 clade. The degree of genetic divergence was incompatible with a recent or direct import of a South Asian lineage and was more consistent with diversification in an under-sampled Indian Ocean/South Asia network or outside this region in Africa. With a single Sierra Leone genome, the source and extent of local transmission remain unresolved. These findings underscore the benefits of integrating differential diagnostics and genomics into routine care for febrile illness and sustaining regional arboviral surveillance.